RIZZI, Federica Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 3.787
EU - Europa 3.206
AS - Asia 2.209
SA - Sud America 219
AF - Africa 38
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.476
Nazione #
US - Stati Uniti d'America 3.698
CN - Cina 984
IT - Italia 741
SG - Singapore 680
IE - Irlanda 578
SE - Svezia 417
FI - Finlandia 358
DE - Germania 270
HK - Hong Kong 257
UA - Ucraina 221
BR - Brasile 200
NL - Olanda 127
RO - Romania 119
FR - Francia 106
TR - Turchia 87
CA - Canada 75
AT - Austria 73
GB - Regno Unito 51
IN - India 46
RU - Federazione Russa 46
IR - Iran 38
BE - Belgio 30
VN - Vietnam 28
BD - Bangladesh 25
CZ - Repubblica Ceca 19
CI - Costa d'Avorio 18
ID - Indonesia 17
AU - Australia 9
ES - Italia 8
JP - Giappone 8
KR - Corea 8
SK - Slovacchia (Repubblica Slovacca) 6
AZ - Azerbaigian 5
CH - Svizzera 5
EU - Europa 5
MX - Messico 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
BG - Bulgaria 4
LT - Lituania 4
ZA - Sudafrica 4
EC - Ecuador 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
IQ - Iraq 3
KE - Kenya 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PA - Panama 3
PL - Polonia 3
PT - Portogallo 3
UZ - Uzbekistan 3
BI - Burundi 2
BO - Bolivia 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
Totale 9.476
Città #
Dublin 574
Chandler 520
Singapore 410
Ashburn 346
Santa Clara 346
Jacksonville 272
Hong Kong 257
Ann Arbor 230
Parma 229
Dearborn 211
Beijing 177
Nanjing 145
Boardman 134
Focsani 112
Shanghai 99
Princeton 93
San Mateo 91
Izmir 72
Munich 62
Jinan 60
Vienna 57
Toronto 50
Shenyang 49
Wilmington 47
Marseille 46
Helsinki 43
Hebei 39
Nanchang 38
Moscow 36
Hefei 35
Des Moines 34
Turku 33
Dallas 32
Columbus 31
Council Bluffs 30
Changsha 29
Brussels 28
Nuremberg 28
Kunming 27
Leawood 27
Milan 26
Bologna 25
Fremont 25
Guangzhou 24
Los Angeles 24
Zhengzhou 24
Haikou 22
São Paulo 21
Chicago 20
New York 20
The Dalles 20
Rome 19
Abidjan 18
Falls Church 18
Jiaxing 18
Redmond 18
Jakarta 17
Seattle 17
Tianjin 17
Dong Ket 16
Houston 16
Augusta 15
Modena 14
London 13
Piacenza 13
Taizhou 13
Trieste 13
Ardabil 12
Ardea 12
Frankfurt am Main 12
Taiyuan 12
Bremen 11
Norwalk 10
Brno 9
Chengdu 9
Hangzhou 9
Las Vegas 9
Monmouth Junction 9
Ningbo 9
Ottawa 9
Reggio Emilia 9
Woodbridge 9
Zanjan 9
Bari 8
Belo Horizonte 8
Carpi 8
Fuzhou 8
Mumbai 8
Padova 8
Tokyo 8
Amsterdam 7
Brooklyn 7
Grafing 7
Kocaeli 7
New Delhi 7
Atlanta 6
Bratislava 6
Giugliano in Campania 6
Lanzhou 6
Salvador 6
Totale 5.965
Nome #
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 403
Ionizing Radiation Effects on Hs 578Bst Microtubules 241
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 240
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 197
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 168
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 161
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 160
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 159
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 145
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 132
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 129
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 126
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 123
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 123
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 122
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 119
Flexible PBAT-Based Composite Filaments for Tunable FDM 3D Printing 118
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 116
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 114
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 113
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 112
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 109
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 109
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 108
Clusterin is epigenetically repressed in human prostate cancer cells 108
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 108
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 106
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 106
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 105
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 105
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 104
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 104
SERS-based methods for the detection of genomic biomarkers of cancer 103
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 102
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 101
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 100
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 100
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 99
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 99
Clusterin (CLU): From one gene and two transcripts to many proteins 98
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 97
Chemoprevention of human prostate cancer by oral administration of green tea catechins 97
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells 95
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 95
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 95
Effect of cold plasma treatment on physico-chemical parameters and antioxidant activity of minimally processed kiwifruit 90
Clusterin (CLU) and prostate cancer 90
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 90
Effects of Clusterin knock down on prostate cancer progression in the tramp model 88
Clusterin (CLU) and lung cancer 87
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 87
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 87
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 86
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 86
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 86
Anticancer activity of green tea polyphenols in prostate gland 86
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 86
EFFECT OF COLD PLASMA TREATMENT ON THE FUNCTIONAL PROPERTIES OF FRESH-CUT APPLES 86
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 85
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 83
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 81
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 80
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 80
Clusterin is epigenetically repressed in human prostate cancer. 80
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 79
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 78
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model 78
Sviluppo di un metodo in Real Time PCR per la diagnosi e la prognosi molecolare del carcinoma prostatico umano 78
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 76
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 75
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 75
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 74
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 74
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 73
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 72
Redox Status and Proteostasis in Ageing and Disease 71
Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release 69
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 69
Espressione in forma ricombinante di differenti forme di clusterina 68
Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative RT real-time PCR gene profiling 66
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 65
Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update 65
Development of a green fluorescent reporter plasmid for the bio-assay of anti-oxidant compounds 64
Il tè verde nella chemoprevenzione oncologica 63
Effect of plasma exposure time on the polyphenolic profile and antioxidant activity of fresh-cut apples 63
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells 61
Targeting clusterin in prostate cancer 60
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 59
Gene signature of TRAMP mice tumors for classification of Green Tea Catechins –sensitive and –resistant prostate cancer 59
Green tea polyphenols and prostate cancer chemoprevention 58
Nuclear CLU (nCLU) and the fate of the cell 55
Prognostic role of clusterin in resected adenocarcinomas of the lung 50
HUMAN PROSTATE CANCER PREVENTION BY GREEN TEA CATECHINS: THE CLINICAL TRIAL AND PUTATIVE MOLECULAR MECHANISMS OF ACTION 50
Clusterin Expression and Localization Are Affected by Rituximab and Doxorubicin Treatment in Non-Hodgkin Lymphoma Cells and B Lymphocytes 50
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 47
Study on the quality and stability of minimally processed apples impregnated with green tea polyphenols during storage 47
Unexpected Absence of Skeletal Responses to Dietary Magnesium Depletion: Basis for Future Perspectives? 42
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 39
Oxidative Stress, Chronic Inflammation, and Amyloidoses 35
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 34
Totale 9.639
Categoria #
all - tutte 33.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021986 5 62 53 30 228 53 78 49 159 47 184 38
2021/2022571 22 46 8 16 29 16 71 75 26 44 67 151
2022/20232.055 186 208 155 173 137 232 22 137 669 14 82 40
2023/2024746 63 53 30 24 88 148 49 43 23 54 53 118
2024/20252.768 62 148 133 189 289 312 109 103 342 204 442 435
2025/2026248 248 0 0 0 0 0 0 0 0 0 0 0
Totale 9.639